Cargando…
Can a Bayesian belief network for survival prediction in patients with extremity metastases (PATHFx) be externally validated in an Asian cohort of 356 surgically treated patients?
BACKGROUND AND PURPOSE: Predicted survival may influence the treatment decision for patients with skeletal extremity metastasis, and PATHFx was designed to predict the likelihood of a patient dying in the next 24 months. However, the performance of prediction models could have ethnogeographical vari...
Autores principales: | HSIEH, Hsiang-Chieh, LAI, Yi-Hsiang, LEE, Chia-Che, YEN, Hung-Kuan, TSENG, Ting-En, YANG, Jiun-Jen, LIN, Shin-Yiing, HU, Ming-Hsiao, HOU, Chun-Han, YANG, Rong-Sen, WEDIN, Rikard, FORSBERG, Jonathan A, LIN, Wei-Hsin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Journals Sweden, on behalf of the Nordic Orthopedic Federation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463636/ https://www.ncbi.nlm.nih.gov/pubmed/36083697 http://dx.doi.org/10.2340/17453674.2022.4545 |
Ejemplares similares
-
Predicting survival of patients with spinal metastatic disease using PathFx 3.0 – A validation study of 668 patients in Sweden
por: Carrwik, Christian, et al.
Publicado: (2022) -
Estimating Survival in Patients with Operable Skeletal Metastases: An Application of a Bayesian Belief Network
por: Forsberg, Jonathan Agner, et al.
Publicado: (2011) -
External validation of the Bayesian Estimated Tools for Survival (BETS) models in patients with surgically treated skeletal metastases
por: Forsberg, Jonathan Agner, et al.
Publicado: (2012) -
PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic development
por: Wilson, Jennifer L., et al.
Publicado: (2018) -
Memorandum 356: WBB operation in 1983
por: CERN. Geneva. SPS Experiments Committee
Publicado: (1983)